Phase II study of Depocyt intrathecal therapy for prophylaxis of central nervous system acute lymphocytic leukemia

Trial Profile

Phase II study of Depocyt intrathecal therapy for prophylaxis of central nervous system acute lymphocytic leukemia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2005

At a glance

  • Drugs Cytarabine (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Therapeutic Use
  • Sponsors Enzon Pharmaceuticals
  • Most Recent Events

    • 12 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top